NASDAQ:CLDX | EBITDA | Celldex Therapeutics, Inc.

Complete source-backed ebitda history.

Available history
2009-12-31 to 2026-03-31
Data captured

Historical EBITDA

DateEBITDA
2026-03-31-$83.58M
2025-12-31-$86.34M
2025-03-31-$61.87M
2024-12-31-$55.21M
2024-03-31-$39.83M
2023-12-31-$46.87M
2023-03-31-$31.75M
2022-12-31-$27.21M
2022-03-31-$22.45M
2021-12-31-$19.56M
2021-03-31-$15.86M
2020-12-31-$24.03M
2020-03-31-$11.7M
2019-12-31-$11.84M
2019-03-31-$16.59M
2018-12-31-$11.4M
2018-03-31-$118.65M
2017-12-31-$24.5M
2017-03-31-$33.75M
2016-12-31-$33.89M
2016-03-31-$34.96M
2015-12-31-$32.59M
2015-03-31-$30.31M
2014-12-31-$31.43M
2014-03-31-$30.91M
2013-12-31-$21.6M
2013-03-31-$16.93M
2012-12-31-$16.08M
2012-03-31-$12.74M
2011-12-31-$11.83M
2011-03-31-$9.1M
2010-12-31$21.65M

Annual EBITDA

DateEBITDA
2025-12-31-$283.99M
2024-12-31-$191.9M
2023-12-31-$151.53M
2022-12-31-$112.34M
2021-12-31-$68.18M
2020-12-31-$59.43M
2019-12-31-$50.17M
2018-12-31-$152.86M
2017-12-31-$117.11M
2016-12-31-$129.82M
2015-12-31-$126.54M
2014-12-31-$120.04M
2013-12-31-$79.51M
2012-12-31-$56.03M
2011-12-31-$41.15M
2010-12-31-$3.74M
2009-12-31-$34.27M